Burkholderia thailandensis is a nonpathogenic gram-negative bacillus that is closely related to Burkholderia mallei and Burkholderia pseudomallei. We found that B. thailandensis E125 spontaneously produced a bacteriophage, termed E125, which formed turbid plaques in top agar containing B. mallei ATCC 23344. We examined the host range of E125 and found that it formed plaques on B. mallei but not on any other bacterial species tested, including B. thailandensis and B. pseudomallei. Examination of the bacteriophage by transmission electron microscopy revealed an isometric head and a long noncontractile tail. B. mallei NCTC 120 and B. mallei DB110795 were resistant to infection with E125 and did not produce lipopolysaccharide (LPS) O antigen due to IS407A insertions in wbiE and wbiG, respectively. wbiE was provided in trans on a broad-hostrange plasmid to B. mallei NCTC 120, and it restored LPS O-antigen production and susceptibility to E125. The 53,373-bp E125 genome contained 70 genes, an IS3 family insertion sequence (ISBt3), and an attachment site (attP) encompassing the 3 end of a proline tRNA (UGG) gene. While the overall genetic organization of the E125 genome was similar to -like bacteriophages and prophages, it also possessed a novel cluster of putative replication and lysogeny genes. The E125 genome encoded an adenine and a cytosine methyltransferase, and purified bacteriophage DNA contained both N6-methyladenine and N4-methylcytosine. The results presented here demonstrate that E125 is a new member of the supergroup of Siphoviridae that may be useful as a diagnostic tool for B. mallei.
The disease glanders is caused by Burkholderia mallei, a host-adapted pathogen that does not persist in nature outside of its horse host (32) . Glanders is a zoonosis, and humans whose occupations put them into close contact with infected animals can contract the disease. There have been no naturally occurring cases of glanders in North America in the last 60 years, but laboratory workers are still at risk of infection with B. mallei via cutaneous (68) and inhalational (31) routes. Human glanders has been described as a painful and loathsome disease from which few recover without antibiotic intervention (33, 51) . There is little known about the virulence factors of this organism, but a recent report indicates that the capsular polysaccharide is essential for virulence in hamsters and mice (24) .
Burkholderia pseudomallei is the etiologic agent of the glanders-like disease melioidosis (21) . As the names suggest, B. mallei and B. pseudomallei are closely related species (19, 56, 59, 69) . These ␤-Proteobacteria can now be directly compared at the genomic level because the B. pseudomallei K96243 genomic sequence is available at the Sanger Institute website (http://www.sanger.ac.uk/) and the B. mallei ATCC 23344 genomic sequence is available at the TIGR (The Institute for Genomic Research) website (http://www.tigr.org/). Preliminary BLAST (4) comparisons indicate that the genes conserved between these species are ϳ99% identical at the nucleotide level. This high level of nucleotide identity makes it challenging to use nucleic acid-based assays to discriminate between B. mallei and B. pseudomallei (6, 71) .
There are legitimate concerns that B. mallei and B. pseudomallei may be misused as biological weapons (16, 46, 51, 60) , and there is compelling evidence that B. mallei has already been used in this manner (3, 74) . Diagnostic assays should be developed to discriminate between these microorganisms in the event that they are misused in the future. The use of a combination of diagnostic assays may be necessary to discriminate between these species, including nucleic acid-based assays, phenotypic assays (colony morphology, motility, and carbohydrate utilization), enzyme-linked immunosorbent assay, intact cell matrix-assisted laser desorption ionization-time of flight, and bacteriophage susceptibility.
In 1957 Smith and Cherry described eight lysogenic B. pseudomallei strains that produced bacteriophage that were more active on B. mallei than on B. pseudomallei (67) . In fact, bacteriophage E attacked B. mallei strains exclusively. Manzenink et al. (45a) found that 91% of their B. pseudomallei strains were lysogenic and that three bacteriophages, PP19, PP23, and PP33, could be used in combination to identify B. mallei. Unfortunately, these B. mallei-specific bacteriophage were not further characterized and are not readily available. It is interesting that neither study identified bacteriophage production by B. mallei strains.
The purpose of this work was to identify and characterize a B. mallei-specific bacteriophage and make it available to the scientific community. Burkholderia thailandensis is a nonpathogenic soil saprophyte that has been described as B. pseudomallei-like (9, 10) , and there are no published reports describing bacteriophage production by this species. B. thailandensis 1pir (65) , HB101 (7), MC4100 (15) , DH5␣ (Gibco BRL), JM105 (78) , E2348/69 (41) , and DB24 (36) were also used in this study. E. coli was grown at 37°C on Luria-Bertani (LB) agar (Lennox) or in LB broth (Lennox). P. syringae, B. andropogonis, Burkholderia sp. strain 2.2N, Burkholderia sp. strain T-22-8A, B. glathei, and B. caryophylli were grown at 25°C on LB agar or in LB broth containing 4% glycerol. All other bacterial strains were grown at 37°C on LB agar or in LB broth containing 4% glycerol. When appropriate, antibiotics were added at the following concentrations: 100 g of ampicillin, 30 g of chloramphenicol, 25 g of kanamycin, and 15 g of tetracycline per ml for E. coli and 100 g of streptomycin and 50 g of tetracycline per ml for B. thailandensis. B. mallei DD3008 was grown in the presence of 5 g of gentamicin per ml, and B. mallei NCTC 120 (pBHR1) was grown in the presence of 15 g of polymyxin B and 5 g of kanamycin per ml.
Spontaneous bacteriophage production by lysogenic B. thailandensis strains and UV induction experiments. B. thailandensis strains E264, E275, E202, E125, and E251 were grown in LB broth for 18 h at 37°C with shaking (250 rpm). One hundred microliters of each saturated culture was used to inoculate two LB broth (3-ml) subcultures. One set of subcultures was incubated for 5 h under the same conditions. The other set of subcultures was incubated for 3 h, poured into sterile petri dishes in a class II biological safety cabinet, subjected to a hand-held UV light source (254 nm) for 20 s (25 cm above the sample), pipetted back into culture tubes, and incubated for an additional 2 h. Both sets of subcultures were briefly centrifuged to pellet the cells, and the supernatants were filter sterilized (0.45-m-pore-size filters). The samples were serially diluted in suspension medium (SM) (40) , and the numbers of PFU were assessed by using B. mallei ATCC 23344 as the host strain as described below. Bacteriophage was considered to be induced if the titer increased twofold (or more) after exposure to UV light. If bacteriophage titers did not increase twofold, the bacteriophage was not considered to be induced by UV light.
Bacteriophage E125 propagation and DNA purification. The protocols followed for picking plaques, titrating bacteriophage stocks, and preparing plate lysates were the same as those used for bacteriophage (61) , with a few minor modifications. Briefly, 0.1 ml of E125 and 0.1 ml of a saturated culture of B. mallei ATCC 23344 (ϳ5 ϫ 10 8 bacteria) were mixed and incubated at 25°C for 20 min, and 4.8 ml of molten LB top agar (0.7%) containing 4% glycerol was added. The mixture was immediately poured onto LB plates containing 4% glycerol and incubated overnight at 37°C. For preparation of plate lysate stocks, 5 ml of SM was added to the plate, and bacteriophage was eluted overnight at 4°C without shaking. SM was harvested, bacterial debris was separated by centrifugation, and the resulting supernatant was filter sterilized (0.45-m-pore-size filters) and stored at 4°C. Bacteriophage E125 DNA was purified from a plate culture lysate using the Wizard Lambda Preps DNA Purification System (Promega). The E125 lysogen BML10 was isolated from a single turbid plaque formed on ATCC 23344. The plaque was picked with a Pasteur pipette, transferred to a tube containing 3 ml of broth media, and incubated overnight. The saturated culture was spread onto solid media with an inoculating loop, and 10 isolated colonies were tested for their ability to form plaques with E125. All of the colonies were resistant to infection with E125, and one was selected and designated BML10. E125 sensitivity testing. Approximately 10 2 PFU was added to a saturated bacterial culture and incubated at 25°C for 20 min, and 4.8 ml of molten LB top agar (0.7%) containing 4% glycerol was added. The mixture was immediately poured onto a LB plate containing 4% glycerol and incubated overnight at 25 or 37°C, depending on the bacterial species being tested. Bacteria were considered to be sensitive to E125 if they formed plaques under these conditions and resistant if they did not. It should be noted that the positive control, B. mallei ATCC 23344, formed plaques in the presence of E125 after incubation at 25 and 37°C. No bacterial species tested formed plaques in the absence of E125.
Negative staining of E125. Bacteriophage E125 was prepared from 20 ml of a plate culture lysate (see above), incubated at 37°C for 15 min with Nuclease Mixture (Promega), precipitated with Phage Precipitant (Promega), and resuspended in 1 ml of Phage Buffer (Promega). The bacteriophage solution (ϳ100 l) was added to a strip of parafilm M (Sigma), and a formvar-coated nickel grid (400 mesh) was floated on the bacteriophage solution for 30 min at 25°C. Excess fluid was removed, and the grid was placed on a drop of 1% phosphotungstic acid, pH 6.6, for 2 min at 25°C. Excess fluid was removed, and the specimen was examined on a Philips CM100 transmission electron microscope. Nickel grids were glow discharged on the day of use.
DNA manipulation and plasmid conjugation. Restriction enzymes and T4 DNA ligase were purchased from Roche Molecular Biochemicals and were used according to the manufacturer's instructions. DNA fragments used in cloning procedures were excised from agarose gels and purified with a GeneClean III Kit (Bio 101). Bacterial genomic DNA was prepared by using the Masterpure DNA Kit (Epicentre) for methylase dot blot assays and by a previously described protocol (75) for all other experiments. Plasmids were purified from overnight cultures using Wizard Plus SV Minipreps (Promega). The broad-host-range plasmids pBHR1 and pBHR1-wbiE were electroporated into E. coli S17-1pir (12.25 kV/cm) and conjugated to B. mallei NCTC 120 for 8 h as described elsewhere (22) . Similarly, the suicide vector pSKM3.2 was electroporated into E. coli S17-1pir and conjugated to B. thailandensis E125 for 8 h as described elsewhere (22) . The resulting strain, B. thailandensis DD5003, contained pSKM3.2 integrated into the E125 genome at the 3.2-kb HindIII fragment. Chromosomal DNA was isolated from DD5003 and digested with the restriction endonuclease BamHI, and the bacteriophage attachment site and flanking bacterial DNA were obtained by self-cloning (22) .
Immunoblot analysis. Fifty microliters of a saturated broth culture of B. mallei was subjected to centrifugation, and the bacterial pellet was washed with phosphate-buffered saline, pH 7.4. The sample was resuspended in 50 l of sample buffer (4% sodium dodecyl sulfate [SDS], 10% glycerol, 5% 2-mercaptoethanol, [KPL]). Finally, it was washed three times with blocking buffer and once with PBS (pH 7.4) and then incubated with TMB Membrane Peroxidase Substrate (KPL). DNA sequencing and analysis. DNA sequencing was performed at ACGT, Inc. (Northbrook, Ill.) and at LMT Sequencing Lab (Frederick, Md.). Most E125 genes were identified by using GeneMark.hmm (43) , whereas others were identified by visual inspection, guided by BLAST (4) results. DNA and protein sequences were analyzed with GeneJockeyII and MacVector 7.1 software for the Macintosh. The gapped BLASTX and BLASTP programs were used to search the nonredundant sequence database for homologous proteins (4) . In order to determine the nucleotide sequence of the E125 cos sites, we sequenced the ends of E125 DNA directly by using the following primers: COS4, 5Ј-AATCC GGCTCGTCCTTATTC-3Ј and COS10, 5Ј-GTTGCGGTGACGTGGTGGTG-3Ј. The nucleotide sequences obtained contained a gap relative to the ligated E125 ends on pDW9.5, which corresponded to unsequenceable 3Ј ends (64) .
PCR amplifications. PCR products were sized by using agarose electrophoresis and cloned using the pCR2.1 TOPO TA cloning kit (Invitrogen) and chemically competent E. coli TOP10 (Invitrogen). PCR amplifications were performed with a final reaction volume of 100 l and contained 1ϫ Taq PCR Master Mix (Qiagen), 1 M oligodeoxyribonucleotide primers, and approximately 200 ng of genomic DNA. PCR mixtures were transferred to a PTC-150 MiniCycler with a Hot Bonnet accessory (MJ Research) and heated to 97°C for 5 min. This was followed by 30 cycles of a three-temperature cycling protocol (97°C for 30 s, 55°C for 30 s, and 72°C for 2 min) and one cycle at 72°C for 10 min. The eight oligodeoxyribonucleotide primer pairs used in the PCR amplification of the LPS O-antigen gene cluster were as follows: 1-1, 5Ј-CGAGTTCACGGTATCACAA G-3Ј, and 1-2, 5Ј-GTTGTCGTAGAAGTACAGCC-3Ј; 2-1, 5Ј-GGCTGTACTT CTACGACAAC-3Ј, and 2-2, 5Ј-GCATCAGCAGCGGATTGAAG-3Ј; 3-1, 5Ј-CTTCAATCCGCTGCTGATGC-3Ј, and 3-2, 5Ј-GAATGCGACTTCAACAAC AC-3Ј; 4-1, 5Ј-GTGTTGTTGAAGTCGCATTC-3Ј, and 4-2, 5Ј-CATAAACGT TCTGCAGACGC-3Ј; 5-1, 5Ј-GCGTCTGCAGAACGTTTATG-3Ј, and 5-2, 5Ј-GATTTGCTGCAAATAGCGTG-3Ј; 6-1, 5Ј-CACGCTATTTGCAGCAAAT C-3Ј, and 6-2, 5Ј-CGAAGATATCGAGCCAGTGC-3Ј; 7-1, 5Ј-GCACTGGCTC GATATCTTCG-3Ј, and 7-2, 5Ј-CCGAAGCGGTTGAAGAAGTG-3Ј; 8-1A, 5Ј-CTGGAAATGGCTATGAGCAG-3Ј, and 8-2A, 5Ј-AAATGCTCGCGTCATG TTGC-3Ј.
In order to determine the order and orientation of the HindIII fragments in the intact E125 genome, outward-oriented primers specific for the ends of each HindIII fragment (except the 1,068-bp fragment) were synthesized and PCR was performed with E125 genomic DNA and all possible primer combinations. We reasoned that two HindIII fragments were adjacent if we obtained a PCR product with primer pairs specific for the corresponding ends of those fragments. All PCR products were cloned and sequenced to confirm the PCR results. For these PCRs, and all of the PCR experiments mentioned below, the conditions mentioned above were used, with the following exception: we used 72°C for 30 s instead of 72°C for 2 min in the three-temperature cycling protocol. The 14 oligodeoxyribonucleotide primers used in this analysis were as follows: 3.2F, 5Ј-AGACGATCAAGCAACACGAG-3Ј; 3.2R, 5Ј-TCGAAGCGCCAATAAA ACGC-3Ј; 4.4F, 5Ј-CAAGCTCTCTCAGCTTCTCG-3Ј; 4.4R, 5Ј-ACCAGCGG CCATACATTATG-3Ј; 5.5F, 5Ј-GGTCTCCGGATCGTAATTGT-3Ј; 5.5R, 5Ј-TCGTGCGTCAGTTCAAATGG-3Ј; 7.5F, 5Ј-CCAGATCCAGAATACGCAA C-3Ј; 7.5R, 5Ј-ATAACGCGCTTTGTCGATCG-3Ј; 9.5F, 5Ј-GAGTGAAGCCA TCGAAGATC-3Ј; 9.5R, 5Ј-ACGGAAAGGAGCATGTCATC-3Ј; 11F, 5Ј-TCA TCGACGAGGAACTTCAC-3Ј; 11R, 5Ј-AATGATGGTCAGCACGAACG-3Ј; 18F-2, 5Ј-TCAAGGTAGAACAGCGTGTG-3Ј; 18R, 5Ј-GCTCCTTGTCCAA GTAGATG-3Ј.
PCR was performed with genomic DNAs from B. mallei ATCC 23344, B. mallei BML10, E125, and the primers Pro (5Ј-TATACCCGACCGAATTGG-3Ј) and Int (5Ј-TATGACGTGAAGGCACTC-3Ј) to determine if E125 integrated into the proline tRNA (UGG) gene in B. mallei. We obtained a single PCR product of the expected size (550 bp) with B. mallei BML10 DNA. This product was cloned, and its nucleotide sequence was determined. No PCR products were obtained when genomic DNAs from B. mallei ATCC 23344 or E125 were used in the PCR.
Genomic DNA from E125 was used for PCR amplification of gene27 with the following primers: AM-UP, 5Ј-CAAGTTTAAAAACGGCTTTCAC-3Ј, and AM-DOWN, 5Ј-CAGCCAATCGATCAGAACAG-3Ј. The resulting PCR product was cloned, sequenced, and designated pAM1 (Table 1) . Similarly, gene56 was amplified by PCR using E125 genomic DNA and the following primers: CM-UP, 5Ј-CACAGGTGCTGTTCAATCTC-3Ј, and CM-DOWN, 5Ј-CTCAC ATGACCTCCAAAACG-3Ј. The resulting PCR product was cloned, sequenced, and designated pCM1 (Table 1) .
Dot blot assay for DNA methyltransferase activity. The plasmids pCR2.1, pAM1, and pCM1 (Table 1) were electroporated into E. coli DB24, a strain that lacks all endogenous DNA methylation (36) . The transformants were grown overnight in the presence of 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside), and genomic DNA was isolated as described above. Genomic DNA preparations were diluted in Tris-EDTA buffer (10 mM Tris-Cl [pH 7.4], 1 mM EDTA [pH 8.0]) to yield stocks of 150, 50, and 15 ng/l, and 3-l aliquots of each were spotted onto a BA85 nitrocellulose filter (Schleicher & Schuell). Methylase activity was assessed by using rabbit primary antibodies that react specifically with DNA containing N6-methyladenine (m6A) or N4-methylcytosine (m4C) in a dot blot assay, as described previously (36) . The secondary antibody was a peroxidase-labeled goat anti-rabbit IgG (H ϩ L) conjugate (KPL). Primary and secondary antibodies were used at dilutions of 1:50,000 and 1:1,000, respectively. Detection was accomplished by using the luminol system (Amersham/Pharmacia), and exposures were made to hyperfilm-ECL (Amersham/Pharmacia). The film images were digitally captured using a UMAX flatbed scanner (S900) and Adobe Photodeluxe (version 1.1) software for the PowerMac.
GenBank and American Type Culture Collection (ATCC) accession numbers. The nucleotide sequences reported in this paper were deposited in the GenBank database under the accession numbers AF447491 (E125 genome) and AY063741 (B. thailandensis bacteriophage attachment site). E125 was deposited in the ATCC bacteriophage collection and was assigned the accession number ATCC 23344-B1.
RESULTS
B. thailandensis strains spontaneously produce bacteriophage that infect B. mallei. Five strains of B. thailandensis (E125, E202, E251, E264, and E275) were examined for the production of B. mallei-specific bacteriophage. All of the strains, with the exception of E251, spontaneously produced bacteriophage that formed plaques with diameters of 1.5 to 2 mm on B. mallei ATCC 23344. Strain E264 produced two bacteriophages that formed distinct plaques, one turbid and one clear. Strains E125, E202, and E275 each produced a bacteriophage that formed turbid plaques. Bacteriophage production was increased 2-fold (E264 and E275), 6-fold (E125), and 55-fold (E202) by brief exposure to UV light. The clear plaque bacteriophage from E264 was not induced, and UV light did not induce bacteriophage production by E251. We examined the host range of all five B. thailandensis bacteriophages on 10 strains of B. mallei and 13 strains of B. pseudomallei and found that the temperate bacteriophages produced by E264, E202, and E275 formed plaques on 9 of 10 B. mallei strains and on 3 of 13 B. pseudomallei strains. Since these bacteriophages were not specific for B. mallei, they were not further characterized. The clear plaque bacteriophage produced by E264 (LPE264) and the temperate bacteriophage produced by E125 (E125) formed plaques on 8 of 10 and 9 of 10 B. mallei strains, respectively. Neither bacteriophage formed plaques on B. pseudomallei or on B. mallei NCTC 120. Typical yields of plate lysate stocks of LPE264 were 10 5 PFU/ ml, and yields of E125 were 10 8 PFU/ml. Bacteriophage LPE264 was not further characterized in this study due to its low yield and its inability to form plaques on B. mallei NCTC 3709. Taken together, these results indicate that lysogenic B. thailandensis strains exist in nature and that the bacteriophage they harbor are spontaneously produced and infect B. mallei. Bacteriophage E125 is B. mallei specific. The host range of E125 was examined with 139 bacterial strains, including 13 strains of B. mallei, 50 strains of B. pseudomallei, and 32 strains of B. thailandensis (Table 2) . Bacteriophage E125 formed plaques on 9 of 10 B. mallei strains obtained from NCTC and ATCC. It also formed plaques on DD3008, a capsule-deficient mutant derived from ATCC 23344 (24) . Three B. mallei strains were resistant to plaque formation by E125, NCTC 120, DB110795 (a laboratory-passaged derivative of ATCC 15310), and BML10 (ATCC 23344 harboring the E125 prophage).
E125 did not form plaques on any of the B. pseudomallei or B. thailandensis strains used in this study ( E125 is a new member of the family Siphoviridae. Bacteriophage may be tailed, cubic, filamentous, or pleomorphic and can be classified by morphotype and host genus (2) . Numerous negatively stained bacteriophage were examined, and a representative image of E125 is shown in Fig. 1 . E125 possessed an isometric head of 63 nm in diameter and a long noncontractile tail of 203 nm in length and 8 nm in diameter. Based on its B1 morphotype, E125 can be classified as a member of the order Caudovirales and the family Siphoviridae (1, 2). To our knowledge, this is the first bacteriophage of the Siphoviridae family described as being harbored by the host genus Burkholderia (2) .
LPS O antigen is required for plaque formation by E125. Of the 10 B. mallei strains obtained from NCTC and ATCC, only NCTC 120 was resistant to plaque formation by E125 (Table 2) . We hypothesized that resistance was due to the absence of a surface receptor for E125 on NCTC 120. The result obtained with DD3008 demonstrated that the capsular polysaccharide was not the E125 receptor (Table 2) . We next performed an immunoblot on whole-cell lysates of the NCTC and ATCC strains with a commercially available monoclonal antibody (3D11) that reacts with B. mallei LPS O antigen ( Fig.  2A) . All of the NCTC and ATCC B. mallei strains, with the exception of NCTC 120, demonstrated a typical ladder LPS appearance after immunostaining with 3D11 ( Fig. 2A) . The laboratory-passaged derivative of ATCC 15310, termed DB110795, also does not form plaques with E125 (Table 2) . We performed an immunoblot on a whole cell lysate of DB110795 with the monoclonal antibody 3D11 and found that it did not produce LPS O antigen (Fig. 2B ). These results demonstrate that there is a correlation between the absence of LPS O antigen and resistance to plaque formation by E125.
A previous study demonstrated that IS407A is active in B. mallei during serial subculture in vitro. IS407A integrated into the capsule gene cluster in B. mallei DD420 and resulted in a capsule-deficient strain (24) . The LPS O-antigen gene clusters of NCTC 120 and DB110795 were analyzed to determine if this 1.2-kb insertion element (IS) was responsible for the lack of LPS O-antigen production by these strains. The nucleotide sequence of the B. pseudomallei LPS O-antigen gene cluster is known (23) , and it was used to design eight PCR primer pairs that would result in 2-kb amplicons spanning the LPS O-antigen locus in B. mallei. Eight 2-kb amplicons were generated when PCR assays were performed with these primer pairs and genomic DNA from B. pseudomallei 1026b and B. mallei ATCC 23344 (data not shown). When the PCR assays were performed with genomic DNA from NCTC 120 and DB110795, seven 2-kb amplicons and one 3.2-kb amplicon were produced (data not shown). The 3.2-kb amplicons generated using primer pairs 7-1-7-2 (NCTC 120) and 8-1A-8-2A (DB110795) were cloned and sequenced. The sequencing results demonstrate that NCTC 120 and DB110795 harbor IS407A insertions in wbiE and wbiG, respectively. There was a 4-bp duplication of the sequence 5Ј-CTGC-3Ј flanking the insertion site in NCTC 120 and a 4-bp duplication of the sequence 5Ј-GCAG-3Ј flanking the insertion site in DB110795. Interestingly, the B. mallei capsule mutant DD420 harbors an IS407A insertion in wcbF that is also flanked by a duplication of the sequence 5Ј-GCAG-3Ј (24). The wbiE::IS407A mutation in NCTC 120 was complemented by providing the wbiE gene from ATCC 23344 in trans on the broad-host-range plasmid pBHR1 (Table 1 ). Figure 2B shows that NCTC 120 (pBHR1) does not produce LPS O antigen but that NCTC 120 (pBHR1-wbiE) does. Furthermore, NCTC 120 (pBHR1-wbiE) formed plaques with E125, but NCTC 120 (pBHR1) did not. These results demonstrate that the lack of LPS O-antigen production by NCTC 120 is due to an IS407A mutation in wbiE and that the LPS O antigen is required for plaque formation by E125.
BML10 is immune to E125 superinfection and produces LPS O antigen. Lysogenic bacteria are resistant to superinfection by the temperate bacteriophage that they harbor. Following infection, the E125 genome integrates in the B. mallei chromosome at a specific site and becomes a prophage (see below). ATCC 23344 was infected with E125, and a lysogenic derivative was isolated and designated BML10. B. mallei BML10 spontaneously produced approximately 500 E125 per ml of broth culture. In comparison, B. thailandensis E125 spontaneously produced approximately 1,100 E125 per ml of broth culture. As shown in Table 2 , E125 does not form plaques on BML10. Whole-cell lysates of ATCC 23344 and BML10 were analyzed by immunoblot analysis with the monoclonal antibody 3D11, and both strains produced a typical LPS O-antigen banding pattern (Fig. 2B) . As shown above, NCTC 120 and DB110795 are resistant to infection with E125 because they do not produce LPS O antigen. BML10, on the other hand, produces LPS O antigen but is still resistant (immune) to E125 superinfection, probably via a prophage-encoded gene product(s). It should be noted that B. thailandensis E125 also harbors the E125 prophage and is also immune to superinfection with E125 (Table 2) .
Molecular characterization of the bacteriophage E125 genome. The E125 genome was digested with HindIII, and eight fragments were generated of the following sizes: 1.0, 3.2, 4.4, 5.5, 7.3, 9.0, 9.9, and 13.0 kb. The fragments were heated to 80°C, and the 9.0-kb fragment dissociated into two fragments (1.7 and 7.3 kb), suggesting the presence of a cohesive (cos) site on this fragment (data not shown). The eight HindIII fragments were cloned, and their nucleotide sequences were determined. The nucleotide-sequencing results are depicted schematically in Fig. 3 , and pertinent features of E125 genes and gene products are shown in Table 3 .
The E125 genome is a linear molecule of 53,373 bp in length, and it contains 10-base 3Ј single-stranded extensions on the left (3Ј-GCGGGCGAAG-5Ј) and right (5Ј-CGCCCGCTT C-3Ј), as depicted in Fig. 3 . The G ϩ C content of the E125 genome is 61.2%, which is lower than the 69.3% G ϩ C content of the B. thailandensis genome (77) . The E125 genome encodes 70 proteins, and 44% of them show no homology to proteins in the GenBank databases using the BLASTP search algorithm (Table 3 and Fig. 3 ). The bacteriophage genome also harbors a novel IS3 family insertion sequence (45), designated ISBt3 (Table 3 and Fig. 3 ). ISBt3 is 1,318 bp in length, and it has 27-bp terminal inverted repeats flanked by a 3-bp direct duplication. ISBt3 integrated into E125 gene39, suggesting that the encoded protein (gp39) is not essential for a productive lysogenic infection.
Twenty-eight proteins encoded by E125 are similar to pro- teins encoded by other bacteriophage, prophage, or prophagelike elements (Table 3) . Interestingly, there are numerous similarities to HK022 and HK97 (34) and to -like cryptic prophages in E. coli O157 Sakai (52) and E. coli O157 EDL933 (53) . Bacteriophage genomes are composed of a mosaic of multigene modules, each of which encodes a group of proteins involved in a common function, such as DNA packaging, head biosynthesis, tail biosynthesis, host lysis, lysogeny, or replication (11, 28, 34, 37) . The E125 genome contains a unique combination of multigene modules involved in DNA packaging, head morphogenesis, tail morphogenesis, and host lysis ( Fig. 3 and Table 3 ). The relative order of these modules in the E125 genome is similar to that of other Siphoviridae genomes (11, 34, 37, 42) . Since E125 possesses both structural and genetic similarities to the supergroup group of Siphoviridae, it probably should be included with , N15, HK97, HK022, and D3 in the -like genus (11) . Early bacteriophage gene functions (lysogeny and replication) are typically located on the right half of Siphoviriae genomes, as depicted in Fig. 3 (11) . However, the putative lysogeny and replication modules of E125 appear to be unique relative to other members of the Siphoviridae. Some of the unusual proteins encoded by the right half of the E125 genome include a DNA adenine methylase (gp27), a DNA cytosine methylase (gp56), a 3Ј-phosphoadenosine-5Ј-phosphosulfate (PAPS) reductase or PAPS sulfotransferase (gp57), and a chromosome partitioning protein (gp58) (Fig. 3 and Table 3 ). The E125 genome also contains two putative holins, gp70 (class I) and gp24 (class II), to coordinate the programmed release of lysozyme (gp25) from the cytoplasm prior to bacteriophage release (72) . It is currently unknown if gp70, gp24, or both gp70 and gp24 are required for membrane permeabilization during the E125 life cycle. Finally, several recently sequenced bacterial genomes also encode proteins with similarities to gp29, gp30, gp31, gp33, gp37, gp43, gp61, gp67, gp68, and gp69 (Table 3) , suggesting the presence of prophages or prophage remnants in these bacterial genomes. Alternatively, E125 may have acquired these genes via horizontal transfer from a bacterial host, and they may provide a selective advantage to a lysogen harboring this bacteriophage. E125 integrates into a proline tRNA (UGG) gene in B. thailandensis and B. mallei. As with other lambdoid bacteriophages, E125 DNA probably circularizes at the cos sites after it is injected into the bacterial cell and follows one of two possible pathways (14) . The circularized genome may replicate and produce bacteriophage progeny (lytic response), or it may integrate into the bacterial chromosome and be maintained in a quiescent state (lysogenic response). Temperate bacteriophage genomes often contain an attachment site (attP) that they utilize to integrate into a homologous region on the bacterial genome (attB) via site-specific recombination (18) . Since E125 encodes a site-specific integrase (gp34), we were interested in identifying where the E125 genome was integrated in B. thailandensis E125 and B. mallei BML10 and in determining the nucleotide sequences of attP and attB.
Chromosomal DNA flanking one side of the E125 attachment site in B. thailandensis E125 was cloned and sequenced (see Materials and Methods). The nucleotide sequence of this region contained a 49-bp sequence that was identical for the E125 genome and the B. thailandensis E125 chromosome. This sequence corresponded to the 3Ј end of a 77-bp proline tRNA (UGG) gene on the B. thailandensis chromosome (Fig.  4A) . tRNA genes often serve as target sequences for sitespecific integration of temperate bacteriophages, plasmids, and pathogenicity islands (27, 63) . Immediately upstream of the proline tRNA (UGG) gene on the B. thailandensis chromosome was a divergently transcribed gene designated orfB (Fig.  4B) . BLASTP results demonstrated that OrfB was 52% identical to RSc1539, a probable hydrolase protein from R. solanacearum. The B. thailandensis proline tRNA (UGG) gene and orfB were also present in the B. mallei ATCC 23344 genome (http://www.tigr.org/), and they were 100 and 91% identical at the nucleotide level, respectively. Downstream of the proline tRNA (UGG) gene in B. mallei ATCC 23344 was orfA, a gene that encoded a protein with 40% identity to RSc2888, a hypothetical protein from R. solanacearum (Fig. 4B) . In order to determine if E125 integrates in the 3Ј end of the tRNA proline (UGG) gene in B. mallei, we designed PCR primers specific for B. mallei orfA and E125 gene34 (Fig. 4B) . B. mallei ATCC 23344 and E125 DNA did not yield a PCR product with these primers, but B. mallei BML10 did (data not shown). These results, represented schematically in Fig. 4B , demonstrate that bacteriophage E125 integrates into the 3Ј end of the proline tRNA (UGG) gene in B. mallei and B. thailandensis. It should also be noted that attachment at this site leaves the proline tRNA (UGG) gene intact on the right side, as depicted in Fig. 4B .
Survey of B. thailandensis strains for the presence of E125-like prophages. As mentioned above, lysogenic bacteria are immune to superinfection with the same (or similar) bacteriophage that they harbor. The results presented in Table 2 demonstrate that all thirty-two B. thailandensis strains in our collection, including E125, are resistant to infection with E125. To determine if the strains were resistant to infection because they harbored E125-like prophages, genomic DNA was isolated from all strains and PCR was performed with primer pairs specific for four distinct regions of the E125 genome. The primer pairs used were 9.5R and 3.2R (gene9 and gene10), 7.5F and 5.5F (gene21), 18R and 11F (gene42), and 4.4R and 9.5F (gene67). Only ten of the thirty-two B. thailandensis strains yielded positive PCR results with these primer pairs (E96, E100, E125, E253, E254, E256, E263, E264, E286, and E293). As expected, E125 was positive for all of the PCR primer pairs. The only other strain that was positive for all four primer pairs was E286. Strains E253 and E264 yielded positive PCR results for two primer pairs, and all of the other strains were positive for three primer pairs. All 10 B. thailandensis strains spontaneously produced bacteriophage that formed plaques on B. mallei ATCC 23344. Thus, it appears that E96, E100, E253, E254, E256, E263, E264, E286, and E293 all harbor E125-like prophage and may be immune to superinfection with E125. On the other hand, 22 B. thailandensis strains did not yield a positive PCR product with any of the primer pairs and probably do not harbor a E125-like prophage. These observations suggest that the molecular mechanism of E125 resistance in these strains is probably not due to superinfection immunity.
Functional analysis of the putative DNA methyltransferases of E125. E125 encodes two proteins, gp27 and gp56, that contain similarities to Type II DNA methyltransferases (Table 3) . Site-specific DNA methylation usually leads to the formation of three different products: N6-methyladenine (m6A), 5-methylcytosine (m5C), and N4-methylcytosine (m4C). Some tailed bacteriophage genomes contain unusual or modified DNA bases that may be important in protecting the infecting bacteriophage DNA from host restriction endonucleases (1). gp27 is a putative DNA adenine methylase, and gp56 is a putative DNA cytosine methylase. We were interested in determining if gp27 and gp56 were functional DNA methyltransferases.
The plasmids pCR2.1, pAM1, and pCM1 (Table 1) were transformed into E. coli DB24, a strain that is deficient in all of the E. coli DNA methylases (36) , and DNA methylase dot blot assays were performed with rabbit primary antibodies specific for m6A and m4C. Figure 5A shows that the m6A antibody reacted with genomic DNA samples from (positive control) and DB24 (pAM1) but did not react with DB24 (pCR2.1) or DB24 (pCM1). The m6A antibody also reacted with genomic DNA samples from B. mallei BML10 and bacteriophage E125 (Fig. 5A) . On the other hand, there was only background reactivity of the m6A antibody with genomic DNA from B. thailandensis E125 and B. mallei ATCC 23344 (Fig.  5A ). It appears that the E125 m6A methylase has little or no activity in the B. thailandensis lysogen but is very active in the B. mallei lysogen (Fig. 5A , compare E125 and BML10). It is currently unclear if the B. mallei BML10 genome contains m6A or if the positive signal obtained with the m6A antibody is due to the E125 genome, which also contains m6A (Fig.  5A ). Taken together, these results clearly demonstrate that gene27 is expressed in DB24, that gp27 is a functional m6A methylase, and that the E125 genome contains m6A.
The m4C antibody did not react with genomic DNA from DB24 (pCR2.1), DB24 (pAM1), DB24 (pCM1), or B. thailandensis E125, but it did react with DB24 genomic DNA methylated with M.RsaI as a positive control (Fig. 5B) . This indicates that gene56 is not expressed or is inactive in DB24 (pCM1) and B. thailandensis E125. On the other hand, positive signals were obtained when the m4C antibody was reacted with genomic DNA from B. mallei BML10 and E125 (Fig. 5B) . It is likely that gp56 is an m4C methylase because genomic DNA from B. mallei BML10 reacts with the m4C antibody, but B. mallei ATCC 23344 genomic DNA does not (Fig. 5B) . Alternatively, E125 infection may activate a cryptic B. mallei m4C methylase or a E125 protein other than gp56 may be responsible for the m4C methylase activity in B. mallei BML10. It is not clear if the B. mallei BML10 genome contains m4C or if the positive signal obtained with the m4C antibody is strictly due to m4C methylation of the E125 genome (Fig. 5B) . Further studies will be required to determine the DNA specificities of gp27 and gp56.
DISCUSSION
In this study, we isolated and characterized E125, a tailed bacteriophage specific for B. mallei. The host range of E125 was examined by using bacteria from three genera of ␤-Proteobacteria (Burkholderia, Pandoraea, and Ralstonia) and five The LPS O antigen was required for infection with E125, suggesting that this molecule is the bacteriophage receptor. This is similar to the -like bacteriophage D3, which utilizes the LPS O antigen of P. aeruginosa for infection (37, 38) . It is surprising that E125 did not infect B. pseudomallei or B. thailandensis because the chemical structure of the B. mallei LPS O antigen, a heteropolymer of repeating D-glucose and L-talose, is similar to that previously described for these closely related species (10, 12, 35, 54) . In fact, the gene clusters encoding the B. mallei and B. pseudomallei LPS O antigens are 99% identical at the nucleotide level (12, 23) It is also possible that B. pseudomallei and B. thailandensis are immune to superinfection with E125 because they harbor a E125-like prophage. The nucleotide sequence of a 1,068-bp HindIII fragment from a B. mallei-specific bacteriophage produced by B. pseudomallei 1026b (1026b) was recently obtained and was found to be 98% identical to the 1,068-bp HindIII fragment from E125 (D. DeShazer, unpublished data). However, the nucleotide sequences of other HindIII fragments from 1026b displayed no similarities to E125, indicating that 1026b and E125 are distinct bacteriophages that share regions (modules) of genetic similarity. We found that 10 of the 32 B. thailandensis strains in our collection harbor a E125-like prophage, and the genomic sequence of B. pseudomallei K96243 also contains several genes that are nearly identical to E125 genes (http://www.sanger.ac.uk/). Thus, it is clear that some B. pseudomallei and B. thailandensis strains are lysogenic for a E125-like bacteriophage and may be immune to superinfection with E125. It is also important to note that 22 B. thailandensis strains in our collection did not possess an E125-like prophage, suggesting that superinfection immunity alone is not responsible for their resistance to infection with E125.
In this study, we found that B. mallei NCTC 120 and B. mallei DB110795 do not produce LPS O antigens due to IS407A insertions in wbiE and wbiG, respectively. Burtnick et al. (12) have recently obtained identical results with B. mallei NCTC 120 and B. mallei ATCC 15310, the parental strain of B. mallei DB110795. We found that B. mallei ATCC 15310 does produce LPS O antigen ( Fig. 2A) and does not contain the wbiG::IS407A mutation. In fact, the ATCC stock cultures (1964 and 1974) of B. mallei ATCC 15310 do not harbor IS407A insertions in wbiG (Jason Bannan, personal communication). B. mallei DB110795 was obtained by routine laboratory passage of B. mallei ATCC 15310 at the U.S. Army Medical Research Institute of Infectious Diseases (USAM-RIID). The strain used in the study of Burtnick et al. (12) was obtained from USAMRIID and was probably B. mallei DB110795, not B. mallei ATCC 15310. It was previously reported by members of our group that IS407A integrated into a capsular polysaccharide gene during repeated laboratory passage of B. mallei ATCC 23344 (24) . Taken together, these results suggest that IS407A transposition may be relatively common during routine laboratory passage of this microorganism. Serial subculture of B. mallei on laboratory media results in a loss of virulence for animals (48, 49, 51, 57) , and it is tempting to speculate that IS407A transposition is responsible, directly or indirectly, for this phenomenon.
Finally, we found that E125 genomic DNA contained the methylated bases m6A and m4C (Fig. 5) . DNA methylation may protect E125 DNA from host restriction endonucleases (1), or it may be involved in some other aspect of the E125 life cycle. We cloned and expressed E125 gene27 in E. coli and found that gp27 was a functional m6A methylase. We were unable to provide direct evidence that gp56 was a m4C methylase, but it was intriguing that E125 DNA and genomic DNA from a B. mallei lysogen contained m4C. It was surprising that genomic DNA from a B. mallei lysogen contained m6A and m4C, but genomic DNA from a B. thailandensis lysogen did not. We are currently examining the possibility that gp27 and gp56 require host factors for production and/or activity that are present in B. mallei but not in B. thailandensis. Type II DNA methylases specifically bind and methylate recognition sequences on a DNA substrate (58) . The DNA sequence specificities of gp27 and gp56 are currently unknown, but BLASTP results show that gp56 is similar to cytosine methylases that recognize and methylate the sequence 5Ј-CCCGGG-3Ј, which occurs nine times in the E125 genome. E125 DNA was treated with five restriction endonucleases that recognize this sequence (SmaI, XmaI, Cfr9I, PspAI, and XmaCI), and they all cleaved the DNA into nine fragments of the predicted sizes (D. DeShazer and J. A. Jeddeloh, unpublished data). The fact that cleavage was not blocked strongly suggests that this site is not methylated. Further studies are required to determine the specificity of gp27 and gp56 and to understand their role(s) in the E125 life cycle.
